ISO 13485 Medical Device Quality Management System: 3 Real Boundaries — Certificate Holder / Audit Evidence Chain / Quality Agreement: The First 3 Numbers to Ask When a Printer Receives a “Medical Device Packaging Supplier Qualification” Inquiry
💡 💡 At a Glance
ISO 13485 certifies medical device manufacturers, not packaging printers, so it is correct that a printer “cannot provide this certificate,” but this answers only half the question. When a customer requests this certificate on a questionnaire, what is actually required is 3 capabilities: systematized quality management, process validation, and predictable change control. The 3 key figures to clarify are: 1. Written rules for change control, including which material changes require written customer approval, how many days' advance notice is required, and how a lack of response becomes effective; 2. The granularity of traceability, including whether it reaches only the order number or extends to the paper roll number and ink batch number, requiring records to be created at the receiving stage; and 3. Complaint deadlines and the burden of proof, including how many days a valid complaint must be submitted, what evidence is required, and who approves acceptance under concession. Including these 3 items in a quality agreement is more useful than obtaining another system certificate. A system certificate proves that “you have processes,” while a quality agreement proves that “our processes and your processes align.”
A customer in Suzhou producing minimally invasive surgical devices sent a supplier qualification questionnaire with the note: “Please provide a scanned copy of your ISO 13485 certificate.”
The printing plant owner stared at this note for three minutes. He understood one thing: he could not provide this certificate—ISO 13485 is issued to medical device manufacturers and registrants, and packaging printers are not within the certification scope. However, what the customer actually wanted was not the certificate itself, but proof of the printing plant's ability to ensure that its printing processes would not cause problems with the customer's products.
This is one of the most common mismatches in the medical device packaging supply chain. The customer writes a standard number on the questionnaire, the supplier replies, “We do not have this certificate,” and the two sides exchange emails for two weeks without clarifying what is actually required.
When this issue is broken down, it comes down to 3 boundaries.
The First Boundary: The Certificate Holder Boundary—Who Is Certified and Who Is Outside the Certification Scope
The full title of ISO 13485 is “Medical Devices—Quality Management Systems—Requirements for Regulatory Purposes.” Its core logic is that the quality management system established by an “organization manufacturing medical devices” can be accepted by medical device regulations. The certification target is the manufacturer, not the manufacturer's packaging supplier.
Therefore, it is correct for a printer to say, “We do not have ISO 13485,” but this answers only half of the question. The real question is: why did the customer request this certificate on the questionnaire?
When the customer's requirements are translated into terms the printer understands, they usually have 3 levels:
- First level: I need to confirm that your quality management is systematic rather than dependent on the skills of experienced craftsmen. A packaging company can answer this level with ISO 9001. The 3 preparation steps and 4 common rejection issues addressed in packaging company ISO 9001 system audits provide the common foundation for this chain.
- Second level: I need to confirm that the packaging you print will not become the reason for my recall. This level involves process validation and cannot be replaced by system certification.
- Third level: I need to confirm that my changes will not be disrupted by your changes. This is change control—the level that printers should prepare in advance and most frequently overlook.
If the printer writes in its response, “We do not have 13485, but we have ISO 9001 and are willing to participate in your supplier audit process,” this is a qualified response. Writing, “We are a printing plant and do not need 13485 for packaging production,” pushes the customer's question back, leading to a second round of dispute.
There is another important boundary next door: ISO 15378 is “Pharmaceutical Packaging Materials—Production and Use—Quality Management System.” Its certification target is the organization producing packaging materials. If the customer is a pharmaceutical company rather than a medical device manufacturer, the correct benchmark is ISO 15378 rather than ISO 13485. Although the medical and pharmaceutical tracks look similar in documentation, what auditors examine on site is completely different: pharmaceutical companies focus on batch records and change assessments, while medical device manufacturers focus on risk management and process validation. The 3 mandatory requirements for the pharmaceutical packaging materials quality management system concern this pharmaceutical track rather than the medical device track.
The Second Boundary: What Auditors Actually Examine on Site—3 Evidence Chains
When a medical device customer conducts a supplier audit, or when the customer's own quality engineer visits the site, the visit usually lasts only half a day. They will not ask whether you have a management system. They will examine 3 things.
The first: change control. Which supplier provided this batch of paper? Which supplier provided this batch of ink? Do you know when a supplier changes? Have you conducted validation after the change? Where are the validation records?
This is the most critical issue in the medical device packaging supply chain. In a printing plant's daily operations, changing a batch of paper, a container of adhesive, or a die-cutting supplier is usually a single instruction from procurement. In the eyes of a medical device customer, however, this is a change that “may affect the product” and must undergo assessment, validation, and notification. Without this process, the printing plant will become stuck at the first on-site audit—not because its work is poor, but because it has no evidence.
One point is frequently overlooked: the printer must clearly define “which changes require customer approval.” Not every change requires customer consent, but the customer has the right to know the rules. Stating this in the quality agreement is far more useful than including it only in system documentation.
The second: traceability. The customer must be able to trace a finished box back to the paper roll, ink container, machine, and production batch. This is a natural weakness for packaging printers because batch management often extends only to the “order number” and “production date,” rather than the “raw material batch.” Raw material batch traceability must extend to paper roll numbers and supplier batch numbers, which requires records to be created at the receiving stage and cannot be added retrospectively. The “consistency of the same batch number” discussed among the 4 national mandatory standards for pharmaceutical packaging refers to the close counterpart of this requirement in medical device packaging.
The third: records of nonconforming product and customer complaint handling. How did you close the previous customer complaint? Was the product returned, accepted under concession, or absorbed internally? Are there review records? If auditors find that “all complaints were directly returned without analysis,” this indicates that the plant has no ability to handle abnormalities and merely shifts problems outward.
One capability should be highlighted: customer complaint handling is the capability most likely to be underestimated by printers. The compression resistance, drop, vibration, and stacking tests among the 6 packaging testing methods must be considered when a printer submits samples for testing. However, a box returned by a customer often has no test report and only contains the verbal descriptions “the color is incorrect” and “the box is deformed.” Whether the printer can obtain usable information from these two statements is an implicit capability assessed during an on-site audit.
The Third Boundary: What the Customer Really Wants Is a Quality Agreement, Not a Certificate
The “contract” between a printer and a medical device customer usually has 2 layers: the commercial contract and the quality agreement. The commercial contract governs payment, delivery deadlines, and breach of contract. The quality agreement governs technical matters and defines each party's responsibility boundaries.
The 3 provisions that the printer should most actively negotiate in this quality agreement, and which are most frequently omitted, are:
- The deadlines and scope for advance notification of changes. For example: “Changes involving the supplier or grade of ink, adhesive, paper, or coating must be notified to the customer in writing 30 working days in advance; the customer is deemed to have approved the change if no written response is received within 15 working days after receipt.” Without such a provision, any material substitution could trigger a dispute.
- The division of responsibilities for incoming material inspection and release. Does the printer perform 100% inspection or sampling? What standard governs sampling? How long must the printer retain samples when it disputes incoming materials? Does the customer accept the printer's inspection conclusions?
- The handling pathway for nonconforming products. Who approves acceptance under concession, such as downgrading the product for another use? How should the burden of proof and response deadlines for customer complaints be defined?
These 3 provisions are more useful in a quality agreement than obtaining another system certificate. A system certificate proves that “you have processes,” while a quality agreement proves that “our processes and your processes align.” What the customer really fears is not that you lack processes, but that you changed personnel, paper, or ink without anyone knowing.
One practical point should be added: printers also have a natural advantage in medical device packaging—customers will require data for physical testing of sterile barrier systems. The test methods for bacterial barrier performance, sealing, and peel, along with the evidence a printer can provide, form the most demanding section of a medical device packaging order. The 3 categories of sterile medical device packaging requirements and the 5 categories of physical tests in the YY/T 0698 series address these matters. Those two articles approach the subject from a packaging design perspective. This article takes a different perspective: when a customer asks, “What gives you the basis for guaranteeing this?”, what documents should you have on hand?
The First 3 Numbers to Ask When a Printer Receives a “Medical Device Packaging Supplier Qualification” Inquiry
| Figure to request | Specific information | Consequence of not asking |
|---|---|---|
| 1. The boundary of change control | Which material changes require written customer approval, how many days in advance notice must be given, and how a lack of customer response is treated | A routine paper substitution is treated by the customer as an unauthorized change, and the entire batch is held |
| 2. The granularity of traceability | Whether traceability reaches the order number and production date, or extends to the paper roll number and ink batch number | When an incident occurs, the printing plant cannot provide the chain of evidence and loses not only payment for the goods but also the customer's trust |
| 3. The complaint deadline and burden of proof | How many days a customer has to submit a valid complaint, what evidence is required, and who signs acceptance under concession | The customer raises an issue from three months ago, and the printer, having no records, can only accept the loss |
Once these 3 figures are clarified, qualification discussions will usually proceed smoothly in 80% of cases.
One more note based on practical experience with these orders: a medical device customer's first impression of a printing plant often comes not from the qualification questionnaire, but from the first sample box delivered. A clean sample box with complete labeling and a small card explaining its structure—these things can be more persuasive to a quality engineer than a scanned certificate.
Further Reading
- Packaging Company ISO 9001 System Audit: 3 Preparation Steps + 4 Common Audit Rejection Issues—how to prepare for a system audit
- ISO 15378 Pharmaceutical Packaging Materials Quality Management System: 3 Mandatory Requirements—the benchmark standard for pharmaceutical companies
- GB/T 19633 vs YY/T 0698: 3 Real Boundaries of Sterile Barrier Systems—the 2 standards applicable to medical device packaging
- Packaging Compliance: “Self-Declaration vs Third-Party Certification”—3 Real Boundaries—the allocation of responsibility for third-party test reports
- Packaging Specifications: 3 Real Boundaries—Dimension Standards / Material Grades / Process Inspectability—the 3 areas in a customer specification most likely to differ from actual conditions
FAQ
Does a printing plant need to obtain ISO 13485 certification?
In most cases, no. The certification target for ISO 13485 is the medical device manufacturer or registrant, and packaging printers have no corresponding certification body able to accept their applications. Even if an institution accepts the application, its practical value to a printer is limited. What customers really want is evidence of change control, batch traceability, and nonconforming product handling. ISO 9001 combined with a properly defined quality agreement can cover these requirements. A printer should invest more in these records themselves.
The customer requests ISO 13485 on the questionnaire. What should I reply?
Use 3 paragraphs. First, clarify the certification holder by politely explaining that ISO 13485 applies to medical device manufacturers and that the corresponding capabilities of packaging suppliers are demonstrated through system certification and process capability. Second, provide alternatives, including your existing ISO 9001, ISO 14001, ISO 15378 certifications if applicable to pharmaceutical packaging materials, and your willingness to accept an on-site customer audit. Third, map the 3 capabilities the questionnaire is actually seeking to your existing processes and identify the location of the supporting evidence for each item. This is far more useful than simply stating, “We do not have it.”
How detailed must a “change notification” be to be sufficient?
The recipient, scope, deadline, and consequences of no response must all be defined. The scope should cover at least paper, ink, adhesive, coating, die-cutting suppliers, and critical equipment. The deadline should reflect the customer's risk tolerance and is generally 30 working days. The default rule for no response is ideally worded as “deemed approved,” but high-risk projects should state that “the customer reserves the right to veto.” Otherwise, the default rule offers little practical effect. The worst approach is to write only “perform according to customer requirements” in quality system documentation without knowing what those requirements are.
What level of batch traceability is sufficient?
There are 3 levels. The minimum is the order number plus production date, which most printers achieve. The second level includes the paper roll number, ink batch number, and adhesive container number, allowing traceability to a single material issue. The third includes equipment, shift, and operator. A common mistake is assuming the second level is sufficient while overlooking the fact that “one paper roll may span two orders.” Therefore, records must be created during both material receiving and material issuance. What medical device customers truly care about is whether, after a complaint about a particular batch, you can identify all other goods from that same batch within two hours rather than merely identifying the portion already shipped.
Is a customer complaint without a test report and with only two verbal descriptions valid?
Yes, but the printing plant must actively discharge the burden of proof. The printer should take 3 actions. First, ask the customer to document the phenomenon, batch, quantity, and point of discovery—incoming materials, machine setup, production line, shelving, or end use—and restate the verbal description in an email for the customer to confirm. Second, conduct retesting using retained samples and apply whichever of the 6 packaging testing methods are relevant. Third, retrieve the production and sample approval records for the batch to determine whether the issue resulted from process variation or differing acceptance criteria. Proactively providing these 3 items is usually accepted by the customer; waiting for the customer to follow up places the printer in the weaker position of having to explain its actions.
Which takes precedence when the quality agreement conflicts with the commercial contract?
The agreed priority clause governs. The quality agreement usually takes precedence over the commercial contract for technical matters, but this must be stated in both documents to prevent conflicting interpretations. The most common practical problems are not disagreements over general principles. For example, the commercial contract may state a “15-day delivery period,” while the quality agreement states that “time spent awaiting customer sample confirmation does not count toward the delivery period.” If this is not clearly defined, every order results in a dispute. Unifying the start point for calculating delivery, the sample confirmation deadline, and the complaint response deadline in one location is the most cost-effective amendment when signing an agreement.
For the first medical device packaging order, what are the 3 documents that should be prepared first?
The first is the “Change Control Checklist,” listing the suppliers and grades of paper, ink, adhesive, and coating used by the printer, together with rules identifying changes that must be notified to the customer. The second is the “Batch Traceability Form,” defining the record format for material receiving, material issuance, material use, and finished products, with fields for roll numbers and batch numbers. The third is the “Customer Complaint Handling Record,” standardizing the five sections for phenomenon, batch, retesting, determination, and disposition. The blind spots of printing plant audits usually lie not in capability but in records. The 3 common audit blind spots of the BRC Packaging Materials certification for printing plants illustrate the same principle: when an auditor enters the workshop, the first thing examined may not be the records but the waste bin—and what is in the waste bin is also a record.
📚 📚 Related Recommendations
Need a Custom Packaging Solution?
Learn more about packaging, or consult directly for a custom solution and quote
